Lurasidone - Schizophrenia and other psychoses
You are here : Home > Formulary Search > Lurasidone - Schizophrenia and other psychoses
Status 1
- Tablets
Initiation by a Mental Health specialist and stabilisation for a minimum of 1 month before any request to transfer prescribing responsibility.
Second line treatment option in the management of schizophrenia once metabolic syndrome has been identified.
Documentation
PAD Profile
Committee Recommendations (2)
The Surrey Heartlands Integrated Care System Area Prescribing Committee has agreed the length of prescribing of anti-psychotics by the specialist team at Surrey & Borders Partnership NHS Foundation Trust as:
Mental Health specialist initiation and prescribing for at least 1 month and until the patient is stabilised on treatment prior to transfer of care to primary care.
Where a stabilised patient requires a simple, non-complex and non-urgent dose adjustment, this can be managed in primary care on recommendation by the specialist team.
The PCN recommends lurasidone as a treatment option in the management of schizophrenia once metabolic syndrome has been identified. Lurasidone will be initiated by a specialist from Surrey & Borders Partnership NHS Foundation Trust, in line with the lurasidone prescribing pathway (see Documentation). Transfer of prescribing responsibility (to primary care) may be considered following 3 months initial treatment by the specialist.
Other Indications
Below are listed other indications that Lurasidone is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Schizophrenia and other psychoses.